GENETIC BASIS of LEFT VENTRICULAR APICAL HYPOPLASIA
NCT04339582 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 7
Last updated 2020-04-10
Summary
Brief summary Left ventricular apical hypoplasia (LVAH) is a rare cardiomyopathy characterized by a spherical, truncated LV with some degree of systolic dysfunction, an elongated, normally functioning right ventricle that wraps around the distal left ventricle, deficiency of the myocardium within the LV apex with adipose tissue infiltrating the apex and origin of the papillary muscle in the flattened anterior apex. This condition presents with different clinical presentation, ranging from no symptoms to congestive heart failure or malignant tachycardia. The etiology of this condition is currently unknown. The aim of this study is to evaluate the clinical and genetic characteristics of patients with LVAH.
Background Left ventricular apical hypoplasia (LVAH) is described as congenital heart disease with an unusual type of cardiomyopathy that was first described in 2004 by Fernandez-Valls et al. It is an extremely rare disease; to date, only more than twenty cases were described.
The typical imaging features of this cardiomyopathy include: a spherical, truncated LV with some degree of systolic dysfunction; an elongated, normally functioning right ventricle that wraps around the distal left ventricle; deficiency of the myocardium within the LV apex with adipose tissue infiltrating the apex; origin of the papillary muscle in the flattened anterior apex. A 2D echocardiogram and cardiac MRI can successfully indicate different morphological features This rare phenomenon frequently presents with different clinical manifestations according to the age of the disease, from no symptoms in children to congestive heart failure, pulmonary edema, or even malignant tachycardia in adults. Congenital or genetical etiology was proposed to explain the development of this rare cardiomyopathy.
The aim of this study is to evaluate the clinical and genetic characteristics of patients with LVAH.
Methods Study population
The study population is composed by consecutive patients with diagnosis of LVAH. Diagnosis of LVAH is based on echocardiographic or cardiac magnetic resonance (CMR) evidence of all the following diagnostic criteria:
* a spherical, truncated LV with some degree of systolic dysfunction;
* an elongated, normally functioning right ventricle that wraps around the distal left ventricle;
* deficiency of the myocardium within the LV apex with adipose tissue infiltrating the apex;
* origin of the papillary muscle in the flattened anterior apex. Patients enrolled followed a common protocol designed by GL (Monaldi Hospital, AORN Colli, University of Campania "Luigi Vanvitelli"). The study protocol was approved, and written informed consent was obtained from each subject, according to the procedure established by the Ethic Committee of our institution.
Study protocol Patients enrolled underwent a comprehensive clinical-genetic evaluation commonly practiced in our cardiology division. In particular, the basal evaluation, consisted family and personal history, physical examination, blood tests, 12-lead electrocardiogram (ECG) at rest, conventional M-mode, two-dimensional and Doppler echocardiography, 24-hour Holter ECG, and cardiac magnetic resonance (CMR), and genetic testing with whole exome sequencing (WES). Moreover, all patients are clinically revaluated every 6-12 months.
Conditions
- Left Ventricular Apical Hypoplasia (LVAH), New Rare Condition
Sponsors & Collaborators
-
Bambino Gesù Hospital and Research Institute
collaborator OTHER -
Monaldi Hospital
lead OTHER
Eligibility
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-09-20
- Primary Completion
- 2022-03-31
- Completion
- 2023-03-31
Countries
- Italy
Study Locations
More Related Trials
-
Dyskinesia, Heterotaxy and Congenital Heart Disease
NCT00608556 ·Status: COMPLETED
-
Long-term Outcomes of Children With Hypoplastic Left Heart Syndrome and the Impact of Norwood Shunt Type
NCT02455531 ·Status: ACTIVE_NOT_RECRUITING
-
Pediatric Cardiomyopathy Mutation Analysis
NCT02432092 ·Status: RECRUITING
-
Influence of Genetic Polymorphisms on Ventricular Structure and Function in Patients With Single Ventricle Anatomy
NCT00165984 ·Status: COMPLETED
-
Natural History of Apparent Mineralocorticoid Excess Syndrome
NCT00474942 ·Status: COMPLETED
-
End-organ Pathology in Childhood Essential Hypertension
NCT00005180 ·Status: COMPLETED
-
Cardiac Function and Morphology Evaluated by Magnetic Resonance Imaging in Growth Hormone Deficiency and Acromegaly
NCT00970463 ·Status: COMPLETED
-
Etiologic Risk Factors of Cardiovascular Malformations
NCT00005153 ·Status: COMPLETED
-
Variability of Ventricular Mass, Volume, & Ejection Fraction in Pediatric Cardiomyopathy Patients-Pediatric Heart Network
NCT00123071 ·Status: COMPLETED
-
Fetal Ebstein Anomaly and Tricuspid Valve Dysplasia Registry
NCT05225311 ·Status: RECRUITING
-
Single Ventricle Outcome
NCT00308217 ·Status: COMPLETED
-
Study of People With Generalized Arterial Calcification of Infancy (GACI) or Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2)
NCT03478839 ·Status: COMPLETED
-
Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome
NCT06342999 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP)
NCT03489993 ·Status: COMPLETED
-
Effect of PDA Closure on the Left Ventricular Remodeling
NCT04964531 ·Status: UNKNOWN
-
Review of Descending Aortic Flow Reversal in Total Anomalous Pulmonary Venous Connection
NCT00486070 ·Status: TERMINATED
-
Effect of Fetal Aortic Valvuloplasty on Outcomes
NCT05386173 ·Status: RECRUITING
-
Cerebral Anatomy, Hemodynamics and Metabolism
NCT02919956 ·Status: COMPLETED
-
Allogeneic hMSC Injection in Patients With Hypoplastic Left Heart Syndrome
NCT02398604 ·Status: TERMINATED ·Phase: PHASE1
-
Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single Ventricle Physiology
NCT01273857 ·Status: COMPLETED ·Phase: PHASE1
-
Long Term Results in Hypoplastic Aortic Arch Repair in Neonates Using a Glutaraldehyde Treated Autologous Pericardial Patch
NCT03588312 ·Status: UNKNOWN
-
3D Echocardiography Managing Infantile Pompe's Disease
NCT00277979 ·Status: TERMINATED
-
AVAST Anomalies Vasculaires Associées au Syndrome de Turner (Vascular Abnormalities Associated With Turner Syndrome)
NCT02250456 ·Status: UNKNOWN
-
Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study
NCT04338048 ·Status: RECRUITING
-
Electronic Archive of Patients With Diagnosis and Suspected Prenatal Diagnosis of Aortic Coarctation
NCT06759103 ·Status: RECRUITING